TFSA Investors: Should the HMMJ ETF Be Part of Your Portfolio?

The HMMF ETF gives investors an opportunity to access the high-risk, high-reward cannabis space.

| More on:
edit Jars of marijuana

Image source: Getty Images

When you invest your savings in the equity markets, you aim to beat the broader markets and grow long-term wealth. One of the best strategies to achieve your financial goals at an accelerated pace is to buy and hold quality growth stocks. So, you need to identify companies that are part of a rapidly expanding addressable market.

Once you identify these stocks, you can hold them in your TFSA, or Tax-Free Savings Account. The TFSA is a registered account, and any withdrawals in the form of dividends, capital gains, and even interest are exempt from Canada Revenue Agency taxes. The TFSA seems to be a solid option to buy and hold growth stocks, allowing investors to benefit from exponential gains over time.

Companies that are part of the cannabis space have the potential to increase your savings multifold due to the prospects of marijuana legalization in the U.S. and several other regions. According to a report from Grand View Research, the global legal cannabis market might touch US$70.6 billion by 2028, indicating an annual growth rate of 26.7% in the next seven years, making it an extremely lucrative sector.

The cannabis sector carries significant risk

Canadian cannabis companies were on an absolute tear just before the country legalized marijuana for recreational use. However, since the start of 2019, cannabis stocks have grossly underperformed the broader markets.

The optimism surrounding pot legalization quickly faded in the background, as cannabis companies were impacted by a slew of structural issues, including the slower-than-expected rollout of retail stores in major provinces, overvalued acquisitions, competition from a thriving black market, negative profit margins, and much more. This in turn resulted in high inventory levels, a high cash-burn rate, shareholder dilution, as well as multi-million-dollar writedowns.

Canadian cannabis stocks such as Aurora Cannabis, HEXO, Canopy Growth, and Cronos Group are trading 95%, 89%, 69%, and 71%, respectively, below record highs. However, the possibility of marijuana legalization at the federal level south of the border and other international markets might provide cannabis stocks an opportunity to gain momentum once again.

Investors should note that the cannabis sector is still at a nascent stage and can be compared to the dot com bubble of early 2000. It means this space will attract several players, increasing competition as well as consolidation in the upcoming years. There will be a few winners that will grow your investments at a stellar rate. But several other companies may go bankrupt due to the above-mentioned issues.

The HMMJ ETF offers you exposure to the cannabis space

In case you want to invest in the cannabis sector, purchasing an exchange-traded fund like Horizons Marijuana Life Sciences ETF (TSX:HMMJ) might be the best option. An ETF will provide investors exposure to several stocks, thereby reducing overall risk.

The HMMJ ETF aims to replicate the performance of the North American Marijuana Index. The ETF is rebalanced quarterly and provides investors access to a basket of publicly listed life sciences companies in the marijuana industry.

The top holdings of the HMMJ include Tilray, Innovative Industrial Properties, Cronos Group, and Canopy Growth; they account for more than 50% of the index fund. The HMMJ ETF has gained 36% in the last year but is still trading 56% below its all-time high, allowing cannabis investors to buy the dip.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Innovative Industrial Properties. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »